Korean J Thorac Cardiovasc Surg.  2020 Aug;53(4):168-171. 10.5090/kjtcs.2020.53.4.168.

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma

Affiliations
  • 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Abstract

Adjuvant therapy for completely resected esophageal squamous cell carcinoma is lesscommonly applied in clinical practice than neoadjuvant therapy, but it plays a substantialrole in improving survival for esophageal cancer patients. This article presents a concise reviewof the evidence regarding adjuvant therapy for esophageal squamous cell carcinomaand future directions, particularly immunotherapy.

Keyword

Adjuvant therapy; Esophageal neoplasms; Neoadjuvant therapy; Immunotherapy
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr